New Orleans—Although extending life is
clearly a primary goal in treating patients with cancer, concerns about quality
of life are often considered equally important. In recent years, scientists
have discovered that the genetic mutations found in a patient's tumor can
often determine the severity of the disease and the potential for a successful
response to certain therapies. Now they are finding that a patient's genetic
makeup may also play a role in aspects of quality of life—such as a
patient's distress, outlook, and fatigue—following treatment.
Hampton T. Patients' Genes May Influence Quality of Life After Cancer Chemotherapy. JAMA. 2004;292(6):673–674. doi:10.1001/jama.292.6.673
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: